Literature DB >> 19570829

Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus.

Noriko Iikuni1, Elaine V Lourenço, Bevra H Hahn, Antonio La Cava.   

Abstract

In systemic lupus erythematosus (SLE), adaptive CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs) suppress Th cells that help autoantibody (autoAb)-producing B cells. It is not known whether naturally occurring Tregs can directly suppress B cells in SLE without an intermediate suppression of Th cells. This aspect is important for its implications in the natural course of SLE, because most if not all of the clinical and pathologic effects in SLE are associated with a dysregulated production of autoAbs. In this study, we show that natural Tregs can inhibit B cell activity in vitro and in vivo in SLE through cell contact-mediated mechanisms that directly suppress autoAb-producing B cells, including those B cells that increase numerically during active disease. These results indicate that one way by which natural Tregs attempt to limit humoral autoimmunity in SLE is by directly targeting autoreactive B cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19570829      PMCID: PMC2730469          DOI: 10.4049/jimmunol.0901163

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells.

Authors:  Su-jean Seo; Michele L Fields; Jodi L Buckler; Amy J Reed; Laura Mandik-Nayak; Simone A Nish; Randolph J Noelle; Laurence A Turka; Fred D Finkelman; Andrew J Caton; Jan Erikson
Journal:  Immunity       Date:  2002-04       Impact factor: 31.745

2.  CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis.

Authors:  Mary E Morgan; Roger P M Sutmuller; Hendrik J Witteveen; Leonie M van Duivenvoorde; Eric Zanelli; Cornelis J M Melief; Alies Snijders; Rienk Offringa; René R P de Vries; René E M Toes
Journal:  Arthritis Rheum       Date:  2003-05

3.  Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells.

Authors:  Hyung W Lim; Peter Hillsamer; Allison H Banham; Chang H Kim
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

4.  Activated CD4+CD25+ T cells selectively kill B lymphocytes.

Authors:  Dong-Mei Zhao; Angela M Thornton; Richard J DiPaolo; Ethan M Shevach
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

Review 5.  From T to B and back again: positive feedback in systemic autoimmune disease.

Authors:  M J Shlomchik; J E Craft; M J Mamula
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

Review 6.  Manipulation of immune regulation in systemic lupus erythematosus.

Authors:  Antonio La Cava; Celia J Fang; Ram P Singh; Fanny Ebling; Bevra H Hahn
Journal:  Autoimmun Rev       Date:  2005-11       Impact factor: 9.754

7.  Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells.

Authors:  Kenneth J Scalapino; Qizhi Tang; Jeffrey A Bluestone; Mark L Bonyhadi; David I Daikh
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

8.  Ig-reactive CD4+CD25+ T cells from tolerized (New Zealand Black x New Zealand White)F1 mice suppress in vitro production of antibodies to DNA.

Authors:  Antonio La Cava; Fanny M Ebling; Bevra H Hahn
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

9.  Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells.

Authors:  Geoffrey L Stephens; Rebecca S McHugh; Matthew J Whitters; Deborah A Young; Deborah Luxenberg; Beatriz M Carreno; Mary Collins; Ethan M Shevach
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

Review 10.  Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.

Authors:  Shimon Sakaguchi
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

View more
  78 in total

Review 1.  T cells as therapeutic targets in SLE.

Authors:  José C Crispín; Vasileios C Kyttaris; Cox Terhorst; George C Tsokos
Journal:  Nat Rev Rheumatol       Date:  2010-05-11       Impact factor: 20.543

2.  T regulatory cells participate in the control of germinal centre reactions.

Authors:  Carla-Maria Alexander; Lorraine T Tygrett; Alexander W Boyden; Kristy L Wolniak; Kevin L Legge; Thomas J Waldschmidt
Journal:  Immunology       Date:  2011-06-03       Impact factor: 7.397

3.  Defective inhibition of B-cell proliferation by Wiskott-Aldrich syndrome protein-deficient regulatory T cells.

Authors:  Marsilio Adriani; Krysten A Jones; Toru Uchiyama; Martha R Kirby; Christopher Silvin; Stacie M Anderson; Fabio Candotti
Journal:  Blood       Date:  2011-04-22       Impact factor: 22.113

4.  Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo.

Authors:  Janine Gotot; Catherine Gottschalk; Sonny Leopold; Percy A Knolle; Hideo Yagita; Christian Kurts; Isis Ludwig-Portugall
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-11       Impact factor: 11.205

5.  The ups and downs of negative (and positive) selection of B cells.

Authors:  Jean-Claude Weill; Claude-Agnès Reynaud
Journal:  J Clin Invest       Date:  2015-09-14       Impact factor: 14.808

Review 6.  Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis.

Authors:  Jeffrey T Guptill; Madhu Soni; Matthew N Meriggioli
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

7.  Altered profile of regulatory T cells and associated cytokines in mild and moderate dengue.

Authors:  H Tillu; A S Tripathy; P V Reshmi; D Cecilia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-09       Impact factor: 3.267

8.  Systemic lupus erythematosis with severe aplastic anemia successfully treated with rituximab and antithymocyte globulin.

Authors:  Wenbin Liu; Zhiping Hu; Shengyun Lin; Jianghua He; Yuhong Zhou
Journal:  Pak J Med Sci       Date:  2014-03       Impact factor: 1.088

Review 9.  Functional defect in regulatory T cells in myasthenia gravis.

Authors:  Muthusamy Thiruppathi; Julie Rowin; Qin Li Jiang; Jian Rong Sheng; Bellur S Prabhakar; Matthew N Meriggioli
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

10.  Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells.

Authors:  Tuure Kinnunen; Nicolas Chamberlain; Henner Morbach; Jinyoung Choi; Sangtaek Kim; Joseph Craft; Lloyd Mayer; Caterina Cancrini; Laura Passerini; Rosa Bacchetta; Hans D Ochs; Troy R Torgerson; Eric Meffre
Journal:  Blood       Date:  2012-12-05       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.